Urinalysis Market
Urinalysis Market by Product (Consumables [Disposable, Reagents], Instruments [Automated, Microscopy, PoC]), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031
URINALYSIS MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global urinalysis market is projected to grow from USD 4.88 billion in 2026 to USD 7.16 billion by 2031, at a CAGR of 8.0% during the forecast period. The market was valued at USD 4.56 billion in 2025. Market growth is primarily driven by the rising prevalence of urinary tract infections (UTIs), diabetes, and kidney and liver diseases, along with an expanding geriatric population and the associated rise in age-related disorders. The growing adoption of point-of-care (PoC) diagnostic testing is also supporting market expansion by enabling faster, more accessible testing. Furthermore, increasing awareness of preventive healthcare and rising healthcare expenditure, particularly in emerging economies, are encouraging investments in advanced urinalysis products and diagnostic infrastructure. However, the availability of refurbished urine analyzers may limit market growth to some extent.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 4.56 Billion
Current Market Size (2026): USD 4.88 Billion
Forecast Market Size (2031): USD 7.16 Billion
CAGR (2026–2031): 8.0% -
SEGMENT LEADERSHIP:
Regional Leader: Asia Pacific is expected to register the fastest growth in the urinalysis market during the forecast period.
Product Leader: Consumables segment accounted for the largest market share of 72.5% in 2025.
Test Type Leader: Pregnancy & fertility tests segment accounted for the largest market share of 42.8% in 2025.
Application Leader: Disease screening segment accounted for the largest market share in 2025.
Technology Leader: Digital microscopy segment is projected to grow fastest during the forecast period.
End User Leader: Hospitals & clinics segment is expected to register the highest CAGR in the urinalysis market during the forecast period. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Cardinal Health, Danaher Corporation, and Abbott were identified as star players, and are supported by their strong market presence and extensive product portfolios.
High Technology Inc., Agappe Diagnostic Ltd., and Dialab GmbH have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.
The urinalysis market is driven by the rising prevalence of UTIs, diabetes, and kidney and liver diseases, along with the growing geriatric population and the adoption of point-of-care (PoC) testing. Increasing awareness of preventive healthcare and rising healthcare expenditure, particularly in emerging economies, are further supporting investment in advanced urinalysis products and infrastructure. However, the availability of refurbished urine analyzers may restrain market growth to some extent.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The urinalysis market is driven by the rising prevalence of urinary tract infections (UTIs), diabetes, and kidney and liver disorders. Growing awareness of preventive healthcare and the adoption of point-of-care testing are expected to shape the revenue mix of urinalysis product manufacturers. In addition, research laboratories and academic institutions contribute to market growth through collaborations with diagnostic technology providers. These institutions use urinalysis technologies to advance research into disease mechanisms, diagnostic methods, and clinical applications. Such collaborations support technology development, facilitate innovation, and broaden the potential applications of urinalysis products.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
-
Rising geriatric population and subsequent increase in age-associated diseases
Level
-
Availability of refurbished urine analyzers
-
High capital investments and lack of skilled laboratory technicians
Level
-
Growth opportunities in emerging countries
-
Technological advancements in urine analyzers
Level
-
Changing regulatory landscape
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer
The rising prevalence of urinary tract infections (UTIs), diabetes, kidney and liver diseases, and bladder cancer is driving demand for urinalysis. As these conditions become more common, the need for early diagnosis, routine screening, and ongoing disease monitoring is growing. Urinalysis plays a key role in detecting and monitoring several of these conditions. In addition, chronic diseases such as diabetes can lead to kidney complications, further increasing the need for regular urinalysis. Technological advances in automated analyzers and point-of-care testing are improving the accuracy, speed, and convenience of urine testing across clinical and home care settings.
Restraint: High capital investments and lack of skilled laboratory technicians
The increasing demand for diagnostic testing is being challenged by a shortage of skilled laboratory staff in many developed and developing nations. This gap is driven by factors such as a larger patient population, retiring experienced technicians, and a scarcity of trained laboratory professionals. Moreover, strict education and certification standards in certain countries can restrict the pool of qualified personnel. This skilled technician shortage may hinder the smooth functioning of advanced urinalysis systems and slow market growth, especially in healthcare environments with limited resources.
Opportunity: Technological advancements in urine analyzers
The urinalysis field has witnessed significant technological advancements, evolving from visual inspection of test strips to automated systems capable of performing biochemical analysis, sediment analysis, flow cytometry, and digital microscopy. Automated urine analyzers enable faster processing, reduce manual intervention, improve testing consistency, and support higher testing volumes. The increasing adoption of integrated and automated urinalysis systems presents significant opportunities for manufacturers to improve laboratory efficiency and expand the use of advanced urine testing technologies.
Challenge: Changing regulatory landscape
Regulatory requirements for in vitro diagnostic (IVD) products, including urinalysis systems and consumables, are becoming increasingly stringent across major markets such as the US and Europe. Manufacturers must comply with evolving requirements for product classification, performance evaluation, quality systems, labeling, and market authorization. In the US, certain IVD products may require FDA review, including 510(k) clearance, depending on their classification and intended use. The EU has implemented more stringent requirements under the In Vitro Diagnostic Medical Devices Regulation (IVDR). These evolving requirements can increase compliance costs, extend product development timelines, and create challenges for market participants.
URINALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Automated and semi-automated urine analyzers, urine chemistry reagents, consumables | High-throughput testing, accurate and reliable results, streamlined workflow, supports early disease detection and monitoring |
 |
Urine analyzers and consumables for clinical and home testing | Rapid and precise testing, user-friendly interface, efficient workflow integration, supports home and clinical testing |
 |
Urinalysis reagents, dipsticks, consumables, point-of-care testing solutions | Reliable routine testing, cost-effective solutions, broad product range for hospitals and labs, supports chronic disease monitoring |
 |
Automated urine chemistry analyzers and consumables | High-volume automated testing, improved accuracy and consistency, reduces operator error, suitable for large diagnostic labs |
 |
Point-of-care urine analyzers and consumables | Rapid point-of-care results, convenient and portable testing, supports clinical decision-making in hospitals and remote settings |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The urinalysis market ecosystem comprises key stakeholders and activities involved in the development, supply, adoption, and regulation of urinalysis products. It includes consumables and instruments, along with their applications across healthcare settings. Manufacturers are responsible for research, product development, technology advancement, and the commercialization of urinalysis solutions. Distributors, including third-party vendors and e-commerce platforms, support product marketing, distribution, and supply to end users. Research and development activities are conducted by in-house R&D teams, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs) that provide specialized services for product development and manufacturing. End users, including diagnostic laboratories, hospitals and clinics, home care settings, and research laboratories, are key stakeholders that use urinalysis products for diagnostic and monitoring purposes. In addition, investors, funding organizations, and regulatory authorities influence market development by supporting innovation, investment, and regulatory compliance.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Urinalysis Market, By Product
By product, the urinalysis market is segmented into consumables and instruments. The consumables segment holds the largest market share, driven by the recurring use and frequent replacement of products such as test kits, dipsticks, reagents, and disposables. Hospitals, clinics, and diagnostic laboratories require a continuous supply of these products for routine urine testing, and the growing burden of chronic conditions such as diabetes and kidney diseases further supports recurring demand.
Urinalysis Market, By Test Type
By test type, the urinalysis market is segmented into biochemical tests, sediment urinalysis, and pregnancy & fertility tests. The pregnancy & fertility tests segment accounts for the largest market share, supported by rising awareness of reproductive health and family planning, as well as the convenience, accessibility, and rapid results of home-based testing. Biochemical tests and sediment urinalysis also play an important role in detecting and monitoring UTIs, kidney diseases, diabetes, and other health conditions, supporting continued demand for these testing methods.
Urinalysis Market, By Application
By application, the urinalysis market is segmented into disease screening and pregnancy and fertility testing. The disease screening segment holds the largest market share, driven by the rising prevalence of urinary tract infections (UTIs), kidney and liver diseases, diabetes, and other chronic conditions. Growing emphasis on early disease detection, routine health screening, and disease monitoring is driving urinalysis adoption across healthcare settings. Pregnancy and fertility testing also continues to contribute to market demand, particularly through the increasing adoption of convenient home-based diagnostic solutions.
Urinalysis Market, By Technology
By technology, the urinalysis market is segmented into biochemical assays, flow cytometry, digital microscopy, and other technologies. Biochemical assays hold the largest share, driven by their low cost, ease of use, and widespread use in disease screening, point-of-care diagnosis, and pregnancy testing. Flow cytometry and digital microscopy are gaining traction in diagnostic laboratories as demand for automated, high-throughput sediment analysis rises. Other technologies, including molecular diagnostics and biosensors, are seeing steady adoption for rapid pathogen identification and point-of-care applications.
Urinalysis Market, By End User
By end user, the urinalysis market is segmented into diagnostic laboratories, hospitals and clinics, home care settings, and research laboratories and institutes. Diagnostic laboratories account for the largest market share due to their high testing volumes and their role in supporting hospitals, clinics, physicians, and other healthcare providers. Increasing demand for routine disease screening, diagnosis, and monitoring, along with the adoption of automated urinalysis systems, supports the use of these products in diagnostic laboratories. Hospitals and clinics, home care settings, and research laboratories and institutes also contribute to market demand through routine testing, decentralized diagnostics, and research applications.
REGION
Asia Pacific to be fastest-growing region in global urinalysis market during forecast period
Asia Pacific is expected to post the highest CAGR in the urinalysis market over the forecast period, driven by expanding healthcare and diagnostic laboratory infrastructure, rising healthcare spending, and growing adoption of advanced diagnostic technologies. Countries such as China, India, Japan, and South Korea are seeing continued investment in healthcare modernization, laboratory automation, and diagnostic capabilities. Additionally, the rising prevalence of diabetes, kidney diseases, urinary tract infections (UTIs), and other chronic conditions, along with a growing geriatric population, is increasing demand for routine urine testing across the region. Growing awareness of preventive healthcare, early disease detection, and point-of-care testing is further supporting the adoption of urinalysis products in Asia Pacific.
URINALYSIS MARKET: COMPANY EVALUATION MATRIX
In the urinalysis market, Siemens Healthineers AG (Germany) is recognized as a dominant player (Star), supported by its comprehensive urinalysis portfolio, strong global presence, advanced automated urine analyzers, and established laboratory diagnostics capabilities. The company further strengthens its position with integrated, automated urinalysis solutions that support high-throughput testing and laboratory efficiency. In contrast, F. Hoffmann-La Roche Ltd. (Switzerland) is emerging as a key market participant, supported by its broad portfolio of urine analyzers and test strips, strong biochemical urinalysis capabilities, and global distribution network. Roche continues to strengthen its position through technological innovation, product development, automation, and the expansion of its diagnostic solutions across clinical laboratories and healthcare settings.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Siemens Healthineers AG (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Cardinal Health (US)
- Danaher Corporation (US)
- Abbott (US)
- Sysmex Corporation (Japan)
- Thermo Fisher Scientific, Inc.(US)
- Bio-Rad Laboratories, Inc. (US)
- QuidelOrtho Corporation (Japan)
- Waters Corporation (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 4.56 Billion |
| Market Size in 2026 (Value) | USD 4.88 Billion |
| Market Forecast in 2031 (Value) | USD 7.16 Billion |
| Growth Rate | CAGR of 8.0 % from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: URINALYSIS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Country-wise analysis of the urinalysis market across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa | Delivered detailed country-level market sizing, growth forecasts, and demand analysis across major regions, with assessment of disease burden, testing volumes, healthcare infrastructure, and demand for urinalysis instruments and consumables | Incorporated country-specific analysis of UTI, diabetes, and kidney disease prevalence, healthcare expenditure, diagnostic infrastructure, testing capabilities, and regulatory environment to identify high-growth markets and investment opportunities |
| Market share analysis and competitive benchmarking of key urinalysis market companies | Provided detailed competitive benchmarking and market share analysis of leading urinalysis companies based on product portfolio, installed base, geographic presence, technology capabilities, distribution reach, and strategic initiatives across automated analyzers, biochemical testing, sediment analysis, and consumables | Expanded the competitive landscape by profiling leading and emerging players and assessing recent product launches, regulatory approvals, partnerships, acquisitions, geographic expansions, and technology innovations to evaluate future competitive positioning |
| Pricing analysis of urinalysis consumables and instruments | Delivered country-wise pricing analysis of urinalysis instruments and consumables, including automated urine analyzers, test strips, reagents, pregnancy & fertility kits, and associated consumables, with pricing variations assessed by product type, supplier, and end user | Incorporated country-level procurement and tender practices, distributor dynamics, instrument placement models, consumable utilization, and laboratory purchasing patterns to provide a comprehensive assessment of pricing trends and market accessibility across regions |
RECENT DEVELOPMENTS
- July 2026 : Beckman Coulter Diagnostics, a Danaher Corporation (US) company, launched the DxU 1800 System, a fully automated urinalysis solution combining a new urine chemistry analyzer and consumables with market-leading microscopy, designed to help laboratories meet rising diagnostic testing volumes.
- February 2026 : Waters Corporation (US) completed its acquisition of Becton, Dickinson and Company's (US) Biosciences & Diagnostic Solutions business through a Reverse Morris Trust transaction, valued at approximately USD 18.8 billion at closing.
- December 2023 : Siemens Healthineers AG (Germany) launched the Atellica UAS 60 Analyzer, a compact solution designed for automated urine sediment analysis.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
Growth opportunities and latent adjacency in Urinalysis Market
MnM Analyst
Jul, 2023
Below are the top 3 technological advancements in urinalysis market:
1. Automated Urine Analyzers: Automated urine analyzers are sophisticated machines that can rapidly and accurately analyze a urine sample. This technology allows for automated testing of multiple parameters in a single sample, eliminating the need for manual handling and improving the accuracy of results.
2. High-throughput Urine Testing: High-throughput urine testing technology uses robotic and automated systems to process a large number of urine samples at once, significantly reducing the time and cost of performing urinalysis.
3. Point-of-Care Urine Testing: Point-of-care urine testing technology allows for testing to be done quickly and easily in a clinical setting, without the need for a laboratory. This technology is particularly useful for rapid screening and diagnosis of urinary tract infections..
Jane
Jul, 2023
what is the technological advancement in urinalysis market?.